Published in J Epidemiol on June 02, 2012
Adult height and prevalence of coronary artery calcium: the National Heart, Lung, and Blood Institute Family Heart Study. Circ Cardiovasc Imaging (2013) 0.78
The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA (2003) 97.28
Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation (2002) 76.93
Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care (2003) 29.49
Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies. Lancet (2009) 26.09
Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet (2005) 17.08
Waist circumference and all-cause mortality in a large US cohort. Arch Intern Med (2010) 2.88
Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed (2002) 2.88
Adherence to a low-risk, healthy lifestyle and risk of sudden cardiac death among women. JAMA (2011) 2.34
First nationwide study of the prevalence of the metabolic syndrome and optimal cutoff points of waist circumference in the Middle East: the national survey of risk factors for noncommunicable diseases of Iran. Diabetes Care (2009) 2.16
Association between height and coronary heart disease mortality: a prospective study of 35,000 twin pairs. Am J Epidemiol (2006) 1.85
Short stature and risk for mortality and cardiovascular disease events. The Framingham Heart Study. Circulation (1994) 1.85
Adult height and cause-specific mortality: a large prospective study of South Korean men. Am J Epidemiol (2003) 1.50
Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31,199 middle-aged men and women in Finland. Am J Epidemiol (2000) 1.48
Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21,000 deaths in 510,000 men and women. Int J Epidemiol (2009) 1.36
Adult height, stroke, and coronary heart disease. Am J Epidemiol (1998) 1.24
Adult height and the risk of mortality in South Korean women. Am J Epidemiol (2008) 1.24
Height loss in older men: associations with total mortality and incidence of cardiovascular disease. Arch Intern Med (2006) 1.21
Adult socioeconomic position and the association between height and coronary heart disease mortality: findings from 33 years of follow-up in the Whitehall Study. Am J Public Health (2005) 1.18
Adult height and the risk of cardiovascular disease among middle aged men and women in Japan. Eur J Epidemiol (2010) 1.09
Short stature and risk of mortality and cardiovascular disease: negative findings from the NHANES I epidemiologic follow-up study. J Am Coll Cardiol (1996) 1.06
Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil (2006) 1.01
Lifestyle and cardiovascular risk factors in 2001 child-parent pairs: the PEP Family Heart Study. Atherosclerosis (2010) 0.97
Body height is associated with decreased long-term stroke but not coronary heart disease mortality? Stroke (2002) 0.92
Childhood socio-economic position and risk of coronary heart disease in middle age: a study of 49,321 male conscripts. Eur J Public Health (2010) 0.89
Short stature and cardiovascular disease among men and women from two southeastern New England communities. Int J Epidemiol (1998) 0.85
Height loss and future coronary heart disease in London: the Whitehall II study. J Epidemiol Community Health (2010) 0.82
Re: "association between height and coronary heart disease mortality: a prospective study of 35,000 twin pairs". Am J Epidemiol (2006) 0.79
Height loss starting in middle age predicts increased mortality in the elderly. J Bone Miner Res (2012) 0.77
Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid (2011) 8.77
Prevention of non-communicable disease in a population in nutrition transition: Tehran Lipid and Glucose Study phase II. Trials (2009) 2.92
Beneficial effects of a Dietary Approaches to Stop Hypertension eating plan on features of the metabolic syndrome. Diabetes Care (2005) 2.76
Dairy consumption is inversely associated with the prevalence of the metabolic syndrome in Tehranian adults. Am J Clin Nutr (2005) 2.25
Clinical usefulness of the Framingham cardiovascular risk profile beyond its statistical performance: the Tehran Lipid and Glucose Study. Am J Epidemiol (2012) 2.20
The association between diet quality indices and obesity: Tehran Lipid and Glucose Study. Arch Iran Med (2012) 2.07
Adolescence metabolic syndrome or adiposity and early adult metabolic syndrome. J Pediatr (2013) 1.97
Reproducibility and relative validity of food group intake in a food frequency questionnaire developed for the Tehran Lipid and Glucose Study. J Epidemiol (2010) 1.92
A single test of antimullerian hormone in late reproductive-aged women is a good predictor of menopause. Menopause (2009) 1.90
Clustering of metabolic abnormalities in adolescents with the hypertriglyceridemic waist phenotype. Am J Clin Nutr (2006) 1.89
Predicting age at menopause from serum antimüllerian hormone concentration. Menopause (2011) 1.85
High prevalence of the metabolic syndrome in Iranian adolescents. Obesity (Silver Spring) (2006) 1.74
Population-based incidence of Type 2 diabetes and its associated risk factors: results from a six-year cohort study in Iran. BMC Public Health (2009) 1.68
High prevalence of undiagnosed diabetes and abnormal glucose tolerance in the Iranian urban population: Tehran Lipid and Glucose Study. BMC Public Health (2008) 1.63
Prevalence of metabolic syndrome in Iranian adult population, concordance between the IDF with the ATPIII and the WHO definitions. Diabetes Res Clin Pract (2007) 1.57
Avicenna, the first to describe thyroid-related orbitopathy. Thyroid (2009) 1.56
Fruit and vegetable consumption and risk factors for cardiovascular disease. Metabolism (2009) 1.52
The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study. Reprod Biol Endocrinol (2011) 1.51
Fast food consumption in Iranian adults; dietary intake and cardiovascular risk factors: Tehran Lipid and Glucose Study. Arch Iran Med (2012) 1.46
Association between interaction and ratio of ω-3 and ω-6 polyunsaturated fatty acid and the metabolic syndrome in adults. Nutrition (2012) 1.45
Prognostic impact of different definitions of metabolic syndrome in predicting cardiovascular events in a cohort of non-diabetic Tehranian adults. Int J Cardiol (2012) 1.44
Mediterranean diets are associated with a lower incidence of metabolic syndrome one year following renal transplantation. Kidney Int (2009) 1.44
Is chronic kidney disease comparable to diabetes as a coronary artery disease risk factor? South Med J (2007) 1.42
Hypertriglyceridemic waist: the point of divergence for prediction of CVD vs. mortality: Tehran Lipid and Glucose Study. Int J Cardiol (2011) 1.41
Trends in overweight, obesity and central fat accumulation among Tehranian adults between 1998-1999 and 2001-2002: Tehran lipid and glucose study. Ann Nutr Metab (2005) 1.39
Contribution of glomerular filtration rate to 10-year cardiovascular and mortality risk among hypertensive adults: Tehran lipid and glucose study. J Clin Hypertens (Greenwich) (2013) 1.38
Reliability and validity of the Modifiable Activity Questionnaire (MAQ) in an Iranian urban adult population. Arch Iran Med (2012) 1.34
Appropriate waist circumference cut-off points among Iranian adults: the first report of the Iranian National Committee of Obesity. Arch Iran Med (2010) 1.33
Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord (2013) 1.32
Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults. Am J Clin Nutr (2005) 1.30
Dietary behaviour of Tehranian adolescents does not accord with their nutritional knowledge. Public Health Nutr (2007) 1.26
Appropriate definition of metabolic syndrome among Iranian adults: report of the Iranian National Committee of Obesity. Arch Iran Med (2010) 1.25
Cardiovascular risk factors in the elderly: the Tehran Lipid and Glucose Study. J Cardiovasc Risk (2003) 1.23
Trends in risk factors for cardiovascular disease among Iranian adolescents: the Tehran Lipid and Glucose Study, 1999-2008. J Epidemiol (2011) 1.23
Trends of obesity and abdominal obesity in Tehranian adults: a cohort study. BMC Public Health (2009) 1.21
High prevalence of chronic kidney disease in Iran: a large population-based study. BMC Public Health (2009) 1.21
Dietary diversity within food groups: an indicator of specific nutrient adequacy in Tehranian women. J Am Coll Nutr (2006) 1.20
Dietary diversity score and cardiovascular risk factors in Tehranian adults. Public Health Nutr (2006) 1.20
General obesity and central adiposity in a representative sample of Tehranian adults: prevalence and determinants. Int J Vitam Nutr Res (2005) 1.19
Adherence to dietary recommendations and risk of metabolic syndrome: Tehran Lipid and Glucose Study. Metabolism (2010) 1.19
Are patients who have metabolic syndrome without diabetes at risk for developing chronic kidney disease? Evidence based on data from a large cohort screening population. Clin J Am Soc Nephrol (2007) 1.17
Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr (2009) 1.14
Leisure Time Physical Activity and Its Determinants among Adults in Tehran: Tehran Lipid and Glucose Study. Int J Prev Med (2011) 1.12
Association between vitamin D and bone mineral density in Iranian postmenopausal women. J Bone Miner Metab (2008) 1.09
Modeling age at menopause using serum concentration of anti-mullerian hormone. J Clin Endocrinol Metab (2013) 1.09
Comparative evaluation of anthropometric measures to predict cardiovascular risk factors in Tehranian adult women. Public Health Nutr (2006) 1.06
A 12-week double-blind randomized clinical trial of vitamin D₃ supplementation on body fat mass in healthy overweight and obese women. Nutr J (2012) 1.06
Prevalence of metabolic syndrome by the Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions and their association with coronary heart disease in an elderly Iranian population. Ann Acad Med Singapore (2009) 1.06
The effects of air pollution on vitamin D status in healthy women: a cross sectional study. BMC Public Health (2010) 1.05
Dietary diversity score in adolescents - a good indicator of the nutritional adequacy of diets: Tehran lipid and glucose study. Asia Pac J Clin Nutr (2004) 1.05
Reduction in incidence of type 2 diabetes by lifestyle intervention in a middle eastern community. Am J Prev Med (2010) 1.04
New and known type 2 diabetes as coronary heart disease equivalent: results from 7.6 year follow up in a Middle East population. Cardiovasc Diabetol (2010) 1.03
Knowledge and attitudes of trainee physicians regarding evidence-based medicine: a questionnaire survey in Tehran, Iran. J Eval Clin Pract (2008) 1.02
Better dietary adherence and weight maintenance achieved by a long-term moderate-fat diet. Br J Nutr (2007) 1.02
Predictive performance of the visceral adiposity index for a visceral adiposity-related risk: type 2 diabetes. Lipids Health Dis (2011) 1.02
Association of total cholesterol versus other serum lipid parameters with the short-term prediction of cardiovascular outcomes: Tehran Lipid and Glucose Study. Eur J Cardiovasc Prev Rehabil (2006) 1.01
Diet quality status of most Tehranian adults needs improvement. Asia Pac J Clin Nutr (2005) 1.01
Waist circumference thresholds provide an accurate and widely applicable method for the discrimination of diabetes. Diabetes Care (2007) 1.01
Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr (2012) 1.00
Diabetes prediction, lipid accumulation product, and adiposity measures; 6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis (2010) 1.00
Intake of dairy products, calcium, magnesium, and phosphorus in childhood and age at menarche in the Tehran Lipid and Glucose Study. PLoS One (2013) 1.00
A point-score system superior to blood pressure measures alone for predicting incident hypertension: Tehran Lipid and Glucose Study. J Hypertens (2011) 0.99
The impact factor-based quality assessment of biomedical research institutes in Iran: effect of impact factor normalization by subject. Arch Iran Med (2007) 0.99
Reliability and validity of the Iranian version of the Pediatric Quality of Life Inventory™ 4.0 Generic Core Scales in adolescents. Qual Life Res (2010) 0.99
Is polycystic ovary syndrome an exception for reproductive aging? Hum Reprod (2010) 0.99
Predictive performances of lipid accumulation product vs. adiposity measures for cardiovascular diseases and all-cause mortality, 8.6-year follow-up: Tehran lipid and glucose study. Lipids Health Dis (2010) 0.98
A prospective study of determinants of the metabolic syndrome in adults. Nutr Metab Cardiovasc Dis (2008) 0.98
A high prevalence of consanguineous and severe congenital hypothyroidism in an Iranian population. J Pediatr Endocrinol Metab (2004) 0.98
Nutritional knowledge, attitude and practice of Tehranian adults and their relation to serum lipid and lipoproteins: Tehran lipid and glucose study. Ann Nutr Metab (2010) 0.98
The metabolic syndrome and incident diabetes: Assessment of alternative definitions of the metabolic syndrome in an Iranian urban population. Diabetes Res Clin Pract (2008) 0.97
Pediatric reference values for serum magnesium levels in Iranian subjects. Scand J Clin Lab Invest (2010) 0.97
Barriers to a healthy lifestyle among obese adolescents: a qualitative study from Iran. Int J Public Health (2010) 0.96
Incidence of chronic kidney disease and its risk factors, results of over 10 year follow up in an Iranian cohort. PLoS One (2012) 0.96